ARGS - Argos Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue1,899.398945.468518.329
Cost of Revenue---
Gross Profit1,899.398945.468518.329
Operating Expenses
Research Development21,656.09638,307.23662,054.823
Selling General and Administrative9,415.69514,203.30111,011.011
Non Recurring33,286.164741.114741.114
Others---
Total Operating Expenses---
Operating Income or Loss-62,458.557-52,306.183-72,547.505
Income from Continuing Operations
Total Other Income/Expenses Net23,189.2481,052.81322.583
Earnings Before Interest and Taxes-39,269.309-51,253.37-72,524.922
Interest Expense1,308.2011,774.742,263.599
Income Before Tax-40,577.51-53,028.11-74,788.521
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-40,577.51-53,028.11-74,788.521
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-40,577.51-53,028.11-74,788.521
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-40,577.51-53,028.11-74,788.521